Key result
Microalbuminuria (30 to 300 mg/d) is a sensitive early marker for cardiovascular disease susceptibility and may serve as an ideal target for early primary prevention.
Design
Review
Authors
Loading...
May inform early CVD risk stratification; leaves open whether targeting microalbuminuria improves primary prevention outcomes.
Microalbuminuria is an early, sensitive marker for cardiovascular disease susceptibility and may be a target for primary prevention.
Zeeuw et al. (2006) conducted a review in Cardiovascular disease. Microalbuminuria was evaluated. Microalbuminuria (30 to 300 mg/d) is a sensitive early marker for cardiovascular disease susceptibility and may serve as an ideal target for early primary prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: